15-Lipoxygenases regulate the production of chemokines in human lung macrophages

British Journal of Pharmacology

Volumn 172, Issue 17, 2015, Pages 4319-4330

  Abrial, C ^a,b   Grassin Delyle, S ^a,b   Salvator, H ^a,b   Brollo, M ^a,b   Naline, E ^a,b   Devillier, P ^a,b  

^a FOCH HOSPITAL   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE 1; ARACHIDONATE 15 LIPOXYGENASE 2; CCL18 CHEMOKINE; CHEMOKINE; CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; ICOSANOID; INDOMETACIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALOX15 PROTEIN, HUMAN; ALOX15B PROTEIN, HUMAN;

AGED; ARTICLE; CARCINOMA; CELL ISOLATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOASSAY; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; ARACHIDONATE 15-LIPOXYGENASE; CELLS, CULTURED; CHEMOKINES; FEMALE; HUMANS; LIPOXYGENASE INHIBITORS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED;

EID: 84938709441     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13210     Document Type: Article

References (61)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors. Br J Pharmacol 170: 1676-1705.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol 170: 1797-1867.
3. Aronoff DM, Peres CM, Serezani CH, Ballinger MN, Carstens JK, Coleman N, et al. (2007). Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities. J Immunol 178: 1628-1634.
4. Back M, Powell WS, Dahlen SE, Drazen JM, Evans JF, Serhan CN, et al. (2014). International Union of Basic and Clinical Pharmacology. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. Br J Pharmacol 171: 3551-3574.
5. Barnes PJ, (2008). Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192.
6. Benoit M, Desnues B, Mege JL, (2008). Macrophage polarization in bacterial infections. J Immunol 181: 3733-3739.
7. Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK, (2013). IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med 54: 1-16.
8. Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH, (1995). Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 151: 1900-1906.
9. Brown CD, Kilty I, Yeadon M, Jenkinson S, (2001). Regulation of 15-lipoxygenase isozymes and mucin secretion by cytokines in cultured normal human bronchial epithelial cells. Inflamm Res 50: 321-326.
10. Buenestado A, Grassin Delyle S, Arnould I, Besnard F, Naline E, Blouquit-Laye S, et al. (2010). The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages. Br J Pharmacol 159: 1304-1311.
11. Buenestado A, Grassin-Delyle S, Guitard F, Naline E, Faisy C, Israel-Biet D, et al. (2012). Roflumilast inhibits the release of chemokines and TNF-alpha from human lung macrophages stimulated with lipopolysaccharide. Br J Pharmacol 165: 1877-1890.
12. Chaitidis P, O'Donnell V, Kuban RJ, Bermudez-Fajardo A, Ungethuem U, Kuhn H, (2005). Gene expression alterations of human peripheral blood monocytes induced by medium-term treatment with the TH2-cytokines interleukin-4 and -13. Cytokine 30: 366-377.
13. Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, Conrad DJ, et al. (2002). Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 32: 1558-1565.
14. Danielsson KN, Rydberg EK, Ingelsten M, Akyurek LM, Jirholt P, Ullstrom C, et al. (2008). 15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration. Atherosclerosis 199: 34-40.
15. Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL, (2011). Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res 50: 115-131.
16. Gillard J, Ford-Hutchinson AW, Chan C, Charleson S, Denis D, Foster A, et al. (1989). L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol 67: 456-464.
17. Gras D, Bourdin A, Vachier I, de Senneville L, Bonnans C, Chanez P, (2012). An ex vivo model of severe asthma using reconstituted human bronchial epithelium. J Allergy Clin Immunol 129: 1259-1266 e1251.
18. Gregus AM, Dumlao DS, Wei SC, Norris PC, Catella LC, Meyerstein FG, et al. (2013). Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia. FASEB J 27: 1939-1949.
19. Hammond VJ, Morgan AH, Lauder S, Thomas CP, Brown S, Freeman BA, et al. (2012). Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ. J Biol Chem 287: 41651-41666.
20. Hashimoto K, Ichiyama T, Hasegawa M, Hasegawa S, Matsubara T, Furukawa S, (2009). Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways. Int Arch Allergy Immunol 149: 275-282.
21. Hempel SL, Monick MM, Hunninghake GW, (1996). Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. Am J Respir Cell Mol Biol 14: 170-176.
22. Ichiyama T, Hasegawa M, Hashimoto K, Matsushige T, Hirano R, Furukawa S, (2009). Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages. Int Arch Allergy Immunol 148: 147-153.
23. Jakiela B, Gielicz A, Plutecka H, Hubalewska M, Mastalerz L, Bochenek G, et al. (2013). Eicosanoid biosynthesis during mucociliary and mucous metaplastic differentiation of bronchial epithelial cells. Prostaglandins Other Lipid Mediat 106: 116-123.
24. Jayawickreme SP, Gray T, Nettesheim P, Eling T, (1999). Regulation of 15-lipoxygenase expression and mucus secretion by IL-4 in human bronchial epithelial cells. Am J Physiol 276 (4 Pt 1): L596-L603.
25. Joshi AD, Oak SR, Hartigan AJ, Finn WG, Kunkel SL, Duffy KE, et al. (2010). Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. BMC Immunol 11: 52.
26. Kuhn H, O'Donnell VB, (2006). Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45: 334-356.
27. Kuo CH, Ko YC, Yang SN, Chu YT, Wang WL, Huang SK, et al. (2011). Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation. J Mol Med (Berl) 89: 29-41.
28. Levy BD, Serhan CN, (2014). Resolution of acute inflammation in the lung. Annu Rev Physiol 76: 467-492.
29. Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, Serhan CN, (1993). Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 92: 1572-1579.
30. Liu C, Xu D, Liu L, Schain F, Brunnstrom A, Bjorkholm M, et al. (2009). 15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 297: L196-L203.
31. Livak KJ, Schmittgen TD, (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method. Methods 25: 402-408.
32. Lundstrom SL, Yang J, Kallberg HJ, Thunberg S, Gafvelin G, Haeggstrom JZ, et al. (2012). Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation. PLoS ONE 7: e33780.
33. Mabalirajan U, Rehman R, Ahmad T, Kumar S, Singh S, Leishangthem GD, et al. (2013). Linoleic acid metabolite drives severe asthma by causing airway epithelial injury. Sci Rep 3: 1349.
34. Magnusson LU, Lundqvist A, Karlsson MN, Skalen K, Levin M, Wiklund O, et al. (2012). Arachidonate 15-lipoxygenase type B knockdown leads to reduced lipid accumulation and inflammation in atherosclerosis. PLoS ONE 7: e43142.
35. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M, (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
36. Martinez FO, Gordon S, Locati M, Mantovani A, (2006). Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177: 7303-7311.
37. Menard L, Pilote S, Naccache PH, Laviolette M, Borgeat P, (1990). Inhibitory effects of MK-886 on arachidonic acid metabolism in human phagocytes. Br J Pharmacol 100: 15-20.
38. Middleton MK, Rubinstein T, Pure E, (2006). Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase. J Immunol 176: 265-274.
39. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. (2014). Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41: 14-20.
40. Norris PC, Gosselin D, Reichart D, Glass CK, Dennis EA, (2014). Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. Proc Natl Acad Sci U S A 111: 12746-12751.
41. Ono E, Mita H, Taniguchi M, Higashi N, Hasegawa M, Miyazaki E, et al. (2009). Concentration of 14,15-leukotriene C4 (eoxin C4) in bronchoalveolar lavage fluid. Clin Exp Allergy 39: 1348-1352.
42. Parkar BA, McCormick ME, Foster SJ, (1990). Leukotrienes do not regulate interleukin 1 production by activated macrophages. Biochem Biophys Res Commun 169: 422-429.
43. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR. (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
44. Pechkovsky DV, Prasse A, Kollert F, Engel KM, Dentler J, Luttmann W, et al. (2010). Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 137: 89-101.
45. Profita M, Vignola AM, Sala A, Mirabella A, Siena L, Pace E, et al. (1999). Interleukin-4 enhances 15-lipoxygenase activity and incorporation of 15(S)-HETE into cellular phospholipids in cultured pulmonary epithelial cells. Am J Respir Cell Mol Biol 20: 61-68.
46. Profita M, Sala A, Riccobono L, Paterno A, Mirabella A, Bonanno A, et al. (2000). 15-Lipoxygenase expression and 15(S)-hydroxyeicoisatetraenoic acid release and reincorporation in induced sputum of asthmatic subjects. J Allergy Clin Immunol 105: 711-716.
47. Pruimboom WM, van Dijk JA, Tak CJ, Garrelds I, Bonta IL, Wilson PJ, et al. (1994). Interactions between cytokines and eicosanoids: a study using human peritoneal macrophages. Immunol Lett 41: 255-260.
48. Rai G, Joshi N, Perry S, Yasgar A, Schultz L, Jung JE, et al. (2010). Discovery of ML351, a potent and selective inhibitor of human 15-lipoxygenase-1. Probe Reports from the NIH Molecular Libraries Program, edn. Bethesda (MD). p^pp.
49. Ratcliffe MJ, Walding A, Shelton PA, Flaherty A, Dougall IG, (2007). Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-alpha release from human alveolar macrophages. Eur Respir J 29: 986-994.
50. Raychaudhuri B, Malur A, Bonfield TL, Abraham S, Schilz RJ, Farver CF, et al. (2002). The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages. J Biol Chem 277: 33344-33348.
51. Sachs-Olsen C, Sanak M, Lang AM, Gielicz A, Mowinckel P, Lodrup Carlsen KC, et al. (2010). Eoxins: a new inflammatory pathway in childhood asthma. J Allergy Clin Immunol 126: 859-867 e859.
52. Sendobry SM, Cornicelli JA, Welch K, Bocan T, Tait B, Trivedi BK, et al. (1997). Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol 120: 1199-1206.
53. Sica A, Mantovani A, (2012). Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795.
54. Staples KJ, Hinks TS, Ward JA, Gunn V, Smith C, Djukanovic R, (2012). Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17. J Allergy Clin Immunol 130: 1404-1412 e1407.
55. Takata S, Matsubara M, Allen PG, Janmey PA, Serhan CN, Brady HR, (1994). Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. J Clin Invest 93: 499-508.
56. Thomson NC, Chaudhuri R, Spears M, Messow CM, Jelinsky S, Miele G, et al. (2014). Arachidonic acid metabolites and enzyme transcripts in asthma are altered by cigarette smoking. Allergy 69: 527-536.
57. Tsai MK, Hsieh CC, Kuo HF, Yang SN, Kuo CH, Huang MY, et al. (2014). Effect of prostaglandin I2 analogs on macrophage inflammatory protein 1alpha in human monocytes via I prostanoid receptor and cyclic adenosine monophosphate. J Investig Med 62: 332-339.
58. Van Dyken SJ, Locksley RM, (2013). Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 31: 317-343.
59. Wuest SJ, Crucet M, Gemperle C, Loretz C, Hersberger M, (2012). Expression and regulation of 12/15-lipoxygenases in human primary macrophages. Atherosclerosis 225: 121-127.
60. Zhao J, Maskrey B, Balzar S, Chibana K, Mustovich A, Hu H, et al. (2009). Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells. Am J Respir Crit Care Med 179: 782-790.
61. Zhao L, Cuff CA, Moss E, Wille U, Cyrus T, Klein EA, et al. (2002). Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J Biol Chem 277: 35350-35356.